相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies
Daniela G. M. Tantalo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Simultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic
Laura T. Morton et al.
MOLECULAR THERAPY (2020)
Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts
George B. McDonald et al.
ANNALS OF INTERNAL MEDICINE (2020)
The therapeutic landscape for cells engineered with chimeric antigen receptors
Matthew MacKay et al.
NATURE BIOTECHNOLOGY (2020)
Differential expansion of T central memory precursor and effector subsets is regulated by division speed
Lorenz Kretschmer et al.
NATURE COMMUNICATIONS (2020)
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
Joao Calmeiro et al.
PHARMACEUTICS (2020)
Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens
Kyra J. Fuchs et al.
FRONTIERS IN IMMUNOLOGY (2020)
CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
Sherly Mardiana et al.
FRONTIERS IN ONCOLOGY (2020)
Minor Histocompatibility Antigen-Specific T Cells
Corinne Summers et al.
FRONTIERS IN PEDIATRICS (2020)
A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia
Anuradha Kirtonia et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
Kitsada Wudhikarn et al.
BLOOD CANCER JOURNAL (2020)
HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study
Peter van Balen et al.
FRONTIERS IN IMMUNOLOGY (2020)
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation
Cristina Toffalori et al.
NATURE MEDICINE (2019)
Modification of Cytotoxic Lymphocytes with T Cell Receptor Specific for Minor Histocompatibility Antigen ACC-1Y
A. M. Pilunov et al.
MOLECULAR BIOLOGY (2019)
Rapid Multiplex Genotyping of 20 HLA-A*02:01 Restricted Minor Histocompatibility Antigens
Dmitrii S. Romaniuk et al.
FRONTIERS IN IMMUNOLOGY (2019)
Protein Degradation and the Pathologic Basis of Disease
John Hanna et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment
Christina Rautenberg et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation
Christoph Schmid et al.
HAEMATOLOGICA (2018)
Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation
Christoph Schmid et al.
HAEMATOLOGICA (2018)
Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT
Sebastian Giebel et al.
EUROPEAN JOURNAL OF CANCER (2018)
Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs
Helena M. Bijen et al.
MOLECULAR THERAPY (2018)
Specific TCell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell Surface
Helena M. Bijen et al.
PROTEOMICS (2018)
In Silico Analysis of the Minor Histocompatibility Antigen Landscape Based on the 1000 Genomes Project
Nadia A. Bykova et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immune Escape of Relapsed AML Cells after Allogeneic Transplantation
M. J. Christopher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II
Peter van Balen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse
Robson G. Dossa et al.
BLOOD (2018)
Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease
Paul J. Martin et al.
BLOOD (2017)
Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients
R. Oostvogels et al.
BONE MARROW TRANSPLANTATION (2017)
MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis
M. Sochalska et al.
ONCOGENE (2017)
Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response
Cornelis A. M. van Bergen et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Alloreactivity: the Janus-face of hematopoietic stem cell transplantation
A. Gratwohl et al.
LEUKEMIA (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma
L. E. Franssen et al.
BONE MARROW TRANSPLANTATION (2017)
Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives
R. Oostvogels et al.
BONE MARROW TRANSPLANTATION (2016)
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
D. Sommermeyer et al.
LEUKEMIA (2016)
Recombinant MHC tetramers for isolation of virus-specific CD8+ cells from healthy donors: Potential approach for cell therapy of posttransplant cytomegalovirus infection
A. S. Vdovin et al.
BIOCHEMISTRY-MOSCOW (2016)
MHC class I-associated peptides derive from selective regions of the human genome
Hillary Pearson et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers
D. P. Granados et al.
LEUKEMIA (2016)
Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames
Celine M. Laumont et al.
NATURE COMMUNICATIONS (2016)
Autosomal Minor Histocompatibility Antigens: How Genetic variants Create Diversity in immune Targets
Marieke Griffioen et al.
FRONTIERS IN IMMUNOLOGY (2016)
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
Anniek B. van der Waart et al.
BLOOD (2014)
Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H
Y. Inaguma et al.
GENE THERAPY (2014)
A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells
Marleen M. van Loenen et al.
HAEMATOLOGICA (2014)
Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors
Luis C. Anton et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides
Diana Paola Granados et al.
NATURE COMMUNICATIONS (2014)
Association of Disparities in Known Minor Histocompatibility Antigens with Relapse-Free Survival and Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation
Willemijn Hobo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Multicenter Analyses Demonstrate Significant Clinical Effects of Minor Histocompatibility Antigens on GvHD and GvL after HLA-Matched Related and Unrelated Hematopoietic Stem Cell Transplantation
Eric Spierings et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway
Sebastien Apcher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Endogenous-peptide-dependent alloreactivity: new scientific insights and clinical implications
L. J. D'Orsogna et al.
TISSUE ANTIGENS (2013)
Origin and Biology of the Allogeneic Response
Fadi G. Lakkis et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid et al.
BLOOD (2012)
MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements
Diana Paola Granados et al.
BLOOD (2012)
Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study
Pauline Meij et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation
Yoshihiro Inamoto et al.
BLOOD (2011)
IL-7 receptor expression identifies suicide gene-modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectors
Attilio Bondanza et al.
BLOOD (2011)
Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia
Marie Bleakley et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
A Polymorphism in the Splice Donor Site of ZNF419 Results in the Novel Renal Cell Carcinoma-Associated Minor Histocompatibility Antigen ZAPHIR
Kelly Broen et al.
PLOS ONE (2011)
High-Throughput Identification of Potential Minor Histocompatibility Antigens by MHC Tetramer-Based Screening: Feasibility and Limitations
Pleun Hombrink et al.
PLOS ONE (2011)
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction
Jeffrey S. Miller et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells
Marie Bleakley et al.
BLOOD (2010)
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens
Edus H. Warren et al.
BLOOD (2010)
Minor histocompatibility antigen HA-1 and HA-2 polymorphisms in Taiwan: frequency and application in hematopoietic stem cell transplantation
Hoi-Yan Lio et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Mixed T cell receptor dimers harbor potentially harmful neoreactivity
Marleen M. van Loenen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
HA-1 and HA-2 minor histocompatibility antigens in Tunisians
M. H. Sellami et al.
TISSUE ANTIGENS (2010)
Effects of Mismatching for Minor Histocompatibility Antigens on Clinical Outcomes in HLA-Matched, Unrelated Hematopoietic Stem Cell Transplants
Stephen Spellman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Steric Hindrance and Fast Dissociation Explain the Lack of Immunogenicity of the Minor Histocompatibility HA-1Arg Null Allele
Eric Spierings et al.
JOURNAL OF IMMUNOLOGY (2009)
Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation.
Luca Vago et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition
Sarah Nicholls et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL
Catherine Matte-Martone et al.
BLOOD (2008)
Graft-versus-leukemia effects of transplantation and donor lymphocytes
Hans-Jochem Kolb
BLOOD (2008)
Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells: application for allogeneic transplantation
Hiroki Torikai et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen
Takakazu Kawase et al.
BLOOD (2007)
A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403
Seitaro Terakura et al.
TRANSPLANTATION (2007)
Phase I/II feasibility study evaluating the generation of leukemia-reactive cytotoxic T lymphocyte lines for treatment of patients with relapsed leukemia after allogeneic stem cell transplantation
Erik Marijt et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
A Uniform Genomic Minor Histocompatibility Antigen Typing Methodology and Database Designed to Facilitate Clinical Applications
Eric Spierings et al.
PLOS ONE (2006)
Bone marrow may be a reservoir of long-lived memory T cells specific for minor histocompatibility antigen
Yoshiki Akatsuka et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL
AG Brickner et al.
BLOOD (2006)
A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia
BC Rijke et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Up-regulated expression in nonhematopoietic tissues of the BCL2A1-derived minor histocompatibility antigens in response to inflammatory cytokines: relevance for allogeneic immunotherapy of leukemia
FM Kloosterboer et al.
BLOOD (2005)
Impact of disparity of minor histocompatibility antigens HA-1, CD31, and CD49B in hematopoietic stem cell transplantation of patients with chronic myeloid leukemia with sibling and unrelated donors
FM Heinemann et al.
TRANSPLANTATION (2004)
Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer
MHM Heemskerk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells
FM Kloosterboer et al.
LEUKEMIA (2004)
Clinical relevance of a newly identified HLA-A24-restricted minor histocompatibility antigen epitope derived from BCL2A1, ACC-1, in patients receiving HLA genotypically matched unrelated bone marrow transplant
T Nishida et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines
LE Gamadia et al.
JOURNAL OF IMMUNOLOGY (2004)
Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region
MHM Heemskerk et al.
BLOOD (2003)
Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors
RMY Barge et al.
EXPERIMENTAL HEMATOLOGY (2003)
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein
E Spierings et al.
BLOOD (2003)
Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens
Y Akatsuka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation
S Mori et al.
BONE MARROW TRANSPLANTATION (2003)
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
WAE Marijt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Abnormal expression of apoptosis-related genes in haematological malignancies:: overexpression of MYC is poor prognostic sign in mantle cell lymphoma
B Nagy et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Minor histocomplatibility antigens as targets of graft-versus-leukemia reactions
JHF Falkenburg et al.
CURRENT OPINION IN HEMATOLOGY (2002)
Acute graft-versus-host disease does not require alloantigen expression on host epithelium
T Teshima et al.
NATURE MEDICINE (2002)
Expression of minor histocompatibility antigen, HA-1, in solid tumor cells
N Fujii et al.
TRANSPLANTATION (2002)
In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens
AM Dickinson et al.
NATURE MEDICINE (2002)
Absence of statistically significant correlation between disparity for the minor histocompatibility antigen HA-1 and outcome after allogeneic hematopoietic cell transplantation
MT Lin et al.
BLOOD (2001)
The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein
RA Pierce et al.
JOURNAL OF IMMUNOLOGY (2001)
Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation
D Gallardo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
G Socié et al.
TRANSPLANTATION (2001)
Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease
P Fontaine et al.
NATURE MEDICINE (2001)
The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing
AG Brickner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
分享论文
